The effects of lithium on a potential cycling model of bipolar disorder.
1. Although bipolar disorder constitutes a major public health problem, with a high risk of suicide and an economic cost exceeding that of unipolar depression, it has received comparatively little attention, particularly at the basic science level. Perhaps as a result of this neglect, there is currently no animal model able to simulate the cyclicity which is its defining characteristic. 2. Consequently, drug development in this area is meager and has proceeded serendipitously rather than empirically. 3. The authors have recently reported that repeated exposure to cocaine and other stressors can induce an oscillation or cycling in a host of neurochemical and physiological systems. 4. In order to test whether such cycling might be of potential relevance to bipolar disorder, the authors examined whether cocaine-induced cyclicity of amphetamine-evoked efflux of dopamine from slices of rat nucleus accumbens and striatum and/or cocaine induced oscillation of a behavior, stress-induced hypoalgesia, could be prevented by lithium, the agent of choice in treating this disease. 5. The authors report that prophylactic treatment with lithium, completely and specifically prevented oscillations in each instance. This may represent an important initial step toward the development of the first cycling model of bipolar disorder.
Antelman
S M
SM
Department of Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA.
Caggiula
A R
AR
Kucinski
B J
BJ
Fowler
H
H
Gershon
S
S
Edwards
D J
DJ
Austin
M C
MC
Stiller
R
R
Kiss
S
S
Kocan
D
D
D000661:Amphetamine / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000503:physiopathology*; D003042:Cocaine / Q000008:administration & dosage / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects / Q000502:physiology; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism*; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D004359:Drug Therapy, Combination; D008094:Lithium / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D008954:Models, Biological; D009714:Nucleus Accumbens / Q000187:drug effects / Q000502:physiology; D010146:Pain; D051381:Rats; D017207:Rats, Sprague-Dawley; D013315:Stress, Psychological
D014150:Antipsychotic Agents; D018765:Dopamine Uptake Inhibitors; D008094:Lithium; D000661:Amphetamine; D003042:Cocaine; D004298:Dopamine